Lofexidine
Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Lofexidine and local guidelines before prescribing.
Alpha-2 agonist
Mechanism
Central alpha-2 agonist.
Uses
Opioid withdrawal symptoms.
Dosing
No dose is given in the chapters. See the BNF.
Side effects
Hypotension, bradycardia, dry mouth, QT prolongation.
Interactions
QT-prolonging drugs.
Contraindications and cautions
QT prolongation
Monitoring
ECG, BP
Pregnancy and breastfeeding
Avoid
Renal and hepatic impairment
Reduce dose in renal and hepatic impairment
Overdose and reversal
Supportive
Special advice
ECG in cardiac risk; taper over days.
More from the textbook: uses, cautions and other points
- Detoxification - gradual reduction of methadone or buprenorphine when the person is stable and ready; lofexidine for symptoms; high relapse and overdose risk after detox (tolerance lost).
Psychiatry: Alcohol, drugs and addiction - Withdrawal in an untreated user - symptomatic treatment (loperamide, antiemetics, lofexidine) or start OST with specialist advice.
Psychiatry: Alcohol, drugs and addiction - Lofexidine | Opioid withdrawal symptoms during detox.
Psychiatry: Alcohol, drugs and addiction
Where it is discussed in the book
- Psychiatry: Alcohol, drugs and addiction (3 mentions)